Aerie Pharmaceuticals NASDAQ AERI
$0.0000 -15.25 -%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 21 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

-
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

201.71M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

0.94
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

47.82M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-
Upcoming events Aerie Pharmaceuticals All events
No upcoming events scheduled

Stock chart Aerie Pharmaceuticals

Stock analysis Aerie Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
- -88.70
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
- 12.53
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-30.82 -27.79
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
-30.82 0.63
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
22.29 -1.16

Price change Aerie Pharmaceuticals per year

9.01$ 21.30$
Min Max

Summary analysis Aerie Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Aerie Pharmaceuticals

Revenue and net income Aerie Pharmaceuticals

All parameters

About company Aerie Pharmaceuticals

Aerie Pharmaceuticals, Inc., an ophthalmic pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma, ocular surface, and retinal diseases in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension; and Rocklatan, a once-daily fixed-dose combination of Rhopressa and latanopros to reduce IOP to treat patients with open-angle glaucoma. The company is also developing AR-15512 to treat signs and symptoms of dry eye; and AR-1105, AR-13503 SR, and AR-14034 SR sustained-release implants focused on retinal diseases. It has a collaborative research, development, and licensing agreement with DSM. Aerie Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Durham, North Carolina.
Address:
4301 Emperor Boulevard, Durham, NC, United States, 27703
Company name: Aerie Pharmaceuticals
Issuer ticker: AERI
ISIN: US00771V1089
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2013-10-25
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.aeriepharma.com

On which stock exchange are Aerie Pharmaceuticals (AERI) stocks traded?

Aerie Pharmaceuticals (AERI) stocks are traded on NASDAQ.

What is the ticker of Aerie Pharmaceuticals stocks (AERI)?

The stock ticker of Aerie Pharmaceuticals’s stocks or in other words, the code is AERI. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Aerie Pharmaceuticals (AERI) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Aerie Pharmaceuticals (AERI) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Aerie Pharmaceuticals (AERI) stocks traded?

Aerie Pharmaceuticals (AERI) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Aerie Pharmaceuticals (AERI) stocks today?

The current price of Aerie Pharmaceuticals stocks on 29.03.2024 is 0 dollars. per share.

What is the dynamics of Aerie Pharmaceuticals (AERI) stocks from the beginning of the year?

Aerie Pharmaceuticals (AERI) quotes have increased by 0% from the beginning of the year up to 0 dollars. per 1 stocks.

How much did Aerie Pharmaceuticals (AERI) stocks increase in марте 2024?

This month Aerie Pharmaceuticals (AERI) quotes have increased by 0% to 0 dollars. per share.

How much are Aerie Pharmaceuticals (AERI) stocks worth?

Today, on October, 29.03.2024 Aerie Pharmaceuticals’s (AERI) stocks cost 0 dollars..

What is the market capitalization of Aerie Pharmaceuticals (AERI)?

Capitalization is the market value of Aerie Pharmaceuticals (AERI) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 29.03.2024, the market capitalization of Aerie Pharmaceuticals (AERI) is estimated at about 0 dollars.